Neuroprotective effect of secreted factors from human adipose stem cells in a rat stroke model

References

• Janowski M, Wagner DC, Boltze J. Stem cell-based tissue replacement after stroke: factual necessity or notorious fiction? Stroke. 2015;46:2354–2363.10.1161/STROKEAHA.114.007803
   PubMed Web of Science ®Google Scholar
• Martino G, Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci. 2006;7:395–406.10.1038/nrn1908
   PubMed Web of Science ®Google Scholar
• Pluchino S, Zanotti L, Rossi B, et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature. 2005;436:266–271.10.1038/nature03889
   PubMed Web of Science ®Google Scholar
• Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076–1084.10.1002/(ISSN)1097-4644
   PubMed Web of Science ®Google Scholar
• Drago D, Cossetti C, Iraci N, et al. The stem cell secretome and its role in brain repair. Biochimie. 2013;95:2271–2285.10.1016/j.biochi.2013.06.020
   PubMed Web of Science ®Google Scholar
• Egashira Y, Sugitani S, Suzuki Y, et al. The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model. Brain Res. 2012;1461:87–95.10.1016/j.brainres.2012.04.033
   PubMed Web of Science ®Google Scholar
• Cho YJ, Song HS, Bhang S, et al. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J Neurosci Res. 2012;90:1794–1802.10.1002/jnr.v90.9
   PubMed Web of Science ®Google Scholar
• Tsai MJ, Tsai SK, Hu BR, et al. Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats. J Biomed Sci. 2014;21:5.10.1186/1423-0127-21-5
   PubMed Web of Science ®Google Scholar
• Teixeira FG, Carvalho MM, Sousa N, et al. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci. 2013;70:3871–3882.10.1007/s00018-013-1290-8
   PubMed Web of Science ®Google Scholar
• Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84–91.10.1161/01.STR.20.1.84
   PubMed Web of Science ®Google Scholar
• Garcia JH, Wagner S, Liu KF, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995;26:627–634; discussion 35.
   PubMed Web of Science ®Google Scholar
• Rogers DC, Campbell CA, Stretton JL, et al. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke. 1997;28:2060–2066; discussion 6.10.1161/01.STR.28.10.2060
   PubMed Web of Science ®Google Scholar
• Bederson JB, Pitts LH, Germano SM, et al. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304–1308.10.1161/01.STR.17.6.1304
   PubMed Web of Science ®Google Scholar
• Belayev L, Khoutorova L, Deisher TA, et al. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke. 2003;34:758–763.10.1161/01.STR.0000056169.45365.15
   PubMed Web of Science ®Google Scholar
• Popp A, Jaenisch N, Witte OW, et al. Identification of ischemic regions in a rat model of stroke. PLoS One. 2009;4:e4764.10.1371/journal.pone.0004764
   PubMed Web of Science ®Google Scholar
• Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine. 2005;32:270–279.10.1016/j.cyto.2005.11.003
   PubMed Web of Science ®Google Scholar
• Sze SK, de Kleijn DP, Lai RC, et al. Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics. 2007;6:1680–1689.10.1074/mcp.M600393-MCP200
   PubMed Web of Science ®Google Scholar
• Nakano N, Nakai Y, Seo TB, et al. Characterization of conditioned medium of cultured bone marrow stromal cells. Neurosci Lett. 2010;483:57–61.10.1016/j.neulet.2010.07.062
   PubMed Web of Science ®Google Scholar
• Hsieh JY, Wang HW, Chang SJ, et al. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One. 2013;8:e72604.10.1371/journal.pone.0072604
   PubMed Web of Science ®Google Scholar
• Kim HO, Choi S-M, Kim H-S. Mesenchymal stem cell-derived secretome and microvesicles as a cell-free therapeutics for neurodegenerative disorders. Tissue Eng Regen Med. 2013;10:93–101.10.1007/s13770-013-0010-7
   Web of Science ®Google Scholar
• Bronckaers A, Hilkens P, Martens W, et al. Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol Ther. 2014;143:181–196.10.1016/j.pharmthera.2014.02.013
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao Z, Gong J, et al. Adipose stem cells-conditioned medium blocks 6-hydroxydopamine-induced neurotoxicity via the IGF-1/PI3 K/AKT pathway. Neurosci Lett. 2014;581:98–102.10.1016/j.neulet.2014.08.033
   PubMed Web of Science ®Google Scholar
• Pawitan JA. Prospect of stem cell conditioned medium in regenerative medicine. Biomed Res Int. 2014;2014:965849.
   PubMed Web of Science ®Google Scholar
• Chang CP, Chio CC, Cheong CU, et al. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clin Sci (Lond). 2013;124:165–176.10.1042/CS20120226
   PubMed Web of Science ®Google Scholar
• Huang P, Gebhart N, Richelson E, et al. Mechanism of mesenchymal stem cell-induced neuron recovery and anti-inflammation. Cytotherapy. 2014;16:1336–1344.10.1016/j.jcyt.2014.05.007
   PubMed Web of Science ®Google Scholar
• Lahiani A, Zahavi E, Netzer N, et al. Human PLacental eXpanded (PLX) mesenchymal-like adherent stromal cells confer neuroprotection to nerve growth factor (NGF)-differentiated PC12 cells exposed to ischemia by secretion of IL-6 and VEGF. Biochim Biophys Acta. 2015;1853:422–430.10.1016/j.bbamcr.2014.11.009
   PubMed Web of Science ®Google Scholar
• Ikegame Y, Yamashita K, Hayashi S, et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy. 2011;13:675–685.10.3109/14653249.2010.549122
   PubMed Web of Science ®Google Scholar
• Wei X, Du Z, Zhao L, et al. IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells. 2009;27:478–488.10.1634/stemcells.2008-0333
   PubMed Web of Science ®Google Scholar
• Zhao L, Wei X, Ma Z, et al. Adipose stromal cells-conditional medium protected glutamate-induced CGNs neuronal death by BDNF. Neurosci Lett. 2009;452:238–240.10.1016/j.neulet.2009.01.025
   PubMed Web of Science ®Google Scholar
• Sun Y, Jin K, Xie L, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111:1843–1851.10.1172/JCI200317977
   PubMed Web of Science ®Google Scholar
• Schabitz WR, Schwab S, Spranger M, et al. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1997;17:500–506.10.1097/00004647-199705000-00003
   PubMed Web of Science ®Google Scholar
• Tsuzuki N, Miyazawa T, Matsumoto K, et al. Hepatocyte growth factor reduces infarct volume after transient focal cerebral ischemia in rats. Acta Neurochir Suppl. 2000;76:311–316.
   PubMedGoogle Scholar
• Harrigan MR, Ennis SR, Sullivan SE, et al. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir (Wien). 2003;145:49–53.10.1007/s00701-002-1035-1
   PubMed Web of Science ®Google Scholar
• Schabitz WR, Berger C, Kollmar R, et al. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke. 2004;35:992–997.10.1161/01.STR.0000119754.85848.0D
   PubMed Web of Science ®Google Scholar
• Kaya D, Gursoy-Ozdemir Y, Yemisci M, et al. VEGF protects brain against focal ischemia without increasing blood–brain permeability when administered intracerebroventricularly. J Cereb Blood Flow Metab. 2005;25:1111–1118.10.1038/sj.jcbfm.9600109
   PubMed Web of Science ®Google Scholar
• Takeshima Y, Nakamura M, Miyake H, et al. Neuroprotection with intraventricular brain-derived neurotrophic factor in rat venous occlusion model. Neurosurgery. 2011;68:1334–1341.10.1227/NEU.0b013e31820c048e
   PubMed Web of Science ®Google Scholar
• Jung JE, Kim GS, Chan PH. Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke. 2011;42:3574–3579.10.1161/STROKEAHA.111.626648
   PubMed Web of Science ®Google Scholar
• Feng Q, Wang YI, Yang Y. Neuroprotective effect of interleukin-6 in a rat model of cerebral ischemia. Exp Ther Med. 2015;9:1695–1701.10.3892/etm.2015.2363
   PubMed Web of Science ®Google Scholar
• Nagahara AH, Tuszynski MH. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov. 2011;10:209–219.10.1038/nrd3366
   PubMed Web of Science ®Google Scholar
• Lange C, Storkebaum E, de Almodovar CR, et al. Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol. 2016;12:439–454.
   PubMed Web of Science ®Google Scholar
• Herz J, Reitmeir R, Hagen SI, et al. Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions. Neurobiol Dis. 2012;45:1077–1085.10.1016/j.nbd.2011.12.026
   PubMed Web of Science ®Google Scholar
• Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:588–610.10.2183/pjab.86.588
   PubMed Web of Science ®Google Scholar
• Cai L, Johnstone BH, Cook TG, et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells. 2007;25:3234–3243.10.1634/stemcells.2007-0388
   PubMed Web of Science ®Google Scholar
• Shang J, Deguchi K, Ohta Y, et al. Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion. J Neurosci Res. 2011;89:86–95.10.1002/jnr.v89:1
   PubMed Web of Science ®Google Scholar
• Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003;374:1–20.10.1042/bj20030407
   PubMed Web of Science ®Google Scholar
• Ali C, Nicole O, Docagne F, et al. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J Cereb Blood Flow Metab. 2000;20:956–966.10.1097/00004647-200006000-00008
   PubMed Web of Science ®Google Scholar
• Williams AJ, Dave JR, Tortella FC. Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration. Neurochem Int. 2006;49:106–112.10.1016/j.neuint.2006.03.018
   PubMed Web of Science ®Google Scholar
• Buchan AM, Li H, Blackburn B. Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-kappaB activation. NeuroReport. 2000;11:427–430.10.1097/00001756-200002070-00041
   PubMed Web of Science ®Google Scholar
• Viatour P, Merville MP, Bours V, et al. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci. 2005;30:43–52.10.1016/j.tibs.2004.11.009
   PubMed Web of Science ®Google Scholar
• Zheng Z, Kim JY, Ma H, et al. Anti-inflammatory effects of the 70 kDa heat shock protein in experimental stroke. J Cereb Blood Flow Metab. 2008;28:53–63.10.1038/sj.jcbfm.9600502
   PubMed Web of Science ®Google Scholar
• Basu A, Haldar S. The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod. 1998;4:1099–1109.10.1093/molehr/4.12.1099
   PubMed Web of Science ®Google Scholar
• Ribeiro CA, Salgado AJ, Fraga JS, et al. The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures). J Tissue Eng Regen Med. 2011;5:668–672.10.1002/term.v5.8
   PubMed Web of Science ®Google Scholar